These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22241690)

  • 1. Deficiency of N-acetylgalactosamine in O-linked oligosaccharides of IgA is a novel biologic marker for Crohn's disease.
    Inoue T; Iijima H; Tajiri M; Shinzaki S; Shiraishi E; Hiyama S; Mukai A; Nakajima S; Iwatani H; Nishida T; Mizushima T; Yasui T; Isaka Y; Kanto T; Tsujii M; Miyoshi E; Wada Y; Takehara T
    Inflamm Bowel Dis; 2012 Sep; 18(9):1723-34. PubMed ID: 22241690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease.
    Shinzaki S; Iijima H; Nakagawa T; Egawa S; Nakajima S; Ishii S; Irie T; Kakiuchi Y; Nishida T; Yasumaru M; Kanto T; Tsujii M; Tsuji S; Mizushima T; Yoshihara H; Kondo A; Miyoshi E; Hayashi N
    Am J Gastroenterol; 2008 May; 103(5):1173-81. PubMed ID: 18177457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of agalactosyl IgG in inflammatory bowel disease patients.
    Nakajima S; Iijima H; Shinzaki S; Egawa S; Inoue T; Mukai A; Hayashi Y; Kondo J; Akasaka T; Nishida T; Kanto T; Morii E; Mizushima T; Miyoshi E; Tsujii M; Hayashi N
    Inflamm Bowel Dis; 2011 Apr; 17(4):927-36. PubMed ID: 20824817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
    Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
    Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
    Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
    World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-based biomarkers used to predict disease activity in Crohn's disease and ulcerative colitis.
    Burakoff R; Pabby V; Onyewadume L; Odze R; Adackapara C; Wang W; Friedman S; Hamilton M; Korzenik J; Levine J; Makrauer F; Cheng C; Smith HC; Liew CC; Chao S
    Inflamm Bowel Dis; 2015 May; 21(5):1132-40. PubMed ID: 25895006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lectin-based immunoassay for aberrant IgG glycosylation as the biomarker for Crohn's disease.
    Shinzaki S; Kuroki E; Iijima H; Tatsunaka N; Ishii M; Fujii H; Kamada Y; Kobayashi T; Shibukawa N; Inoue T; Tsujii M; Takeishi S; Mizushima T; Ogata A; Naka T; Plevy SE; Takehara T; Miyoshi E
    Inflamm Bowel Dis; 2013 Feb; 19(2):321-31. PubMed ID: 23287897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
    Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
    J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies Against Glycoprotein 2 Are Specific Biomarkers for Pediatric Crohn's Disease.
    Shpoliansky M; Roggenbuck D; Pinsker M; Salamon N; Weiss B; Shouval DS; Werner L
    Dig Dis Sci; 2021 Aug; 66(8):2619-2626. PubMed ID: 32886311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
    Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
    J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
    Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
    PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry to the analysis of glycopeptide-containing multiple O-linked oligosaccharides.
    Iwase H; Tanaka A; Hiki Y; Kokubo T; Ishii-Karakasa I; Nishikido J; Kobayashi Y; Hotta K
    J Chromatogr B Biomed Sci Appl; 1998 May; 709(1):145-9. PubMed ID: 9653936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Location-based prediction model for Crohn's disease regarding a novel serological marker, anti-chitinase 3-like 1 autoantibodies.
    Sipeki N; Kovats PJ; Deutschmann C; Schierack P; Roggenbuck D; Papp M
    World J Gastroenterol; 2023 Nov; 29(42):5728-5750. PubMed ID: 38075846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mass spectrometry-based comprehensive lipidomic analysis of plasma from patients with inflammatory bowel disease.
    Iwatani S; Iijima H; Otake Y; Amano T; Tani M; Yoshihara T; Tashiro T; Tsujii Y; Inoue T; Hayashi Y; Takeda K; Hayashi A; Fujita S; Shinzaki S; Takehara T
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1355-1364. PubMed ID: 32285970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2.
    Iwasaki H; Zhang Y; Tachibana K; Gotoh M; Kikuchi N; Kwon YD; Togayachi A; Kudo T; Kubota T; Narimatsu H
    J Biol Chem; 2003 Feb; 278(8):5613-21. PubMed ID: 12438318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
    Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
    Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
    Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA methylation machinery and m
    Motawi TK; Shaker OG; Amr G; Senousy MA
    Clin Chim Acta; 2024 Jul; 561():119831. PubMed ID: 38925436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn's Disease.
    Deutschmann C; Sowa M; Murugaiyan J; Roesler U; Röber N; Conrad K; Laass MW; Bogdanos D; Sipeki N; Papp M; Rödiger S; Roggenbuck D; Schierack P
    J Crohns Colitis; 2019 Jul; 13(7):894-904. PubMed ID: 30753386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.